Products / HIV

Based on data compiled by the WHO (World Health Organization) and CDC (Centers for Disease Control), over 40 million people worldwide are living with HIV/AIDS, of which 38 million are adults. Five million people are newly infected each year and approximately three million die, increasing the total infected population by nearly two million annually.

A staggering 64% of all HIV/AIDS cases are in sub-Saharan Africa, followed by 18% in Southeast Asia. Worldwide, eleven of every one thousand adults (defined as the 15-49 year age group) are HIV-positive; in sub-Saharan Africa, the total is seven and a half percent, rising to over twenty percent in four African nations. The split is fifty-fifty between men and women worldwide.

In these developing nations, there is a great need for rapid diagnostic tests to assist health care workers obtain test results on people in outlying remote areas or deep in inner city neighborhoods where results are needed while the test patient is present in order to proceed, if necessary, with counseling and treatment.

Hema Diagnostic Systems produces a complete range of rapid diagnostic tests to suit every health care need.

The Rapid 1-2-3® HEMA EXPRESS® is a new and novel diagnostic platform technology, which is safe, minimally invasive, simple to use and easy to read. The unique design is a complete self-contained test that eliminates the need for any external equipment or laboratory interpretation. This makes using the Rapid 1-2-3 HEMA® EXPRESS® in the field and in remote locations easy and simple. It can be stored at room temperature and requires no refrigeration at any point of the process. Tests in the Rapid 1-2-3® HEMA EXPRESS® format are very stable in temperature ranging from ambient temperature to temperature exceeding 100°F. The platform is ideal for developing countries that cannot afford highly trained individuals staffing sophisticated laboratories.

Rapid 1-2-3® HEMA EZ® is a sophisticated diagnostic platform technology with particular application in developed areas of the world less sensitive to cost versus performance. The device is the subject of issued U.S. and International patents. The versatility of this device makes it applicable for a variety of point of care settings where rapid test results are required.

The Rapid 1-2-3® HEMA Dipstick Format provides the highest quality GMP-manufactured test strips packed in a desiccated container that preserves the integrity of the products. The test kits come complete with all necessary components to perform tests for our complete portfolio of rapid assays, including sample loops, diluent, test strips and (optional) lancets.

HEMA QuantiFlexx® ELISA products use carefully selected raw material antigens to provide highly sensitive and specific tests, with applicability in worldwide markets. The tests use the traditional Enzyme Linked ImmunoSorbent Assay (ELISA) technology and provide results in only three hours using standard laboratory equipment.